rs17280682

Variant names:

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_176822.4(NLRP14):c.3028C>T(p.Leu1010Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.19 in 1,608,730 control chromosomes in the GnomAD database, including 31,805 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2148 hom., cov: 32)

Exomes 𝑓: 0.19 ( 29657 hom. )

Consequence

NLRP14
NM_176822.4 missense

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.99

Publications

23 publications found

Variant links:

Genes affected

NLRP14 (HGNC:22939): (NLR family pyrin domain containing 14) The protein encoded by this gene belongs to the NALP protein family. Members of the NALP protein family typically contain a NACHT domain, a NACHT-associated domain (NAD), a C-terminal leucine-rich repeat (LRR) region, and an N-terminal pyrin domain (PYD). This protein may play a regulatory role in the innate immune system as similar family members belong to the signal-induced multiprotein complex, the inflammasome, that activates the pro-inflammatory caspases, caspase-1 and caspase-5. [provided by RefSeq, Jul 2008]

NLRP14 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4

Computational evidence support a benign effect (MetaRNN=0.0010507703).

BP6

Variant 11-7070338-C-T is Benign according to our data. Variant chr11-7070338-C-T is described in ClinVar as Benign. ClinVar VariationId is 1222316.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BA1

GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.21 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_176822.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	NLRP14	NM_176822.4	MANE Select	c.3028C>T	p.Leu1010Phe	missense	Exon 11 of 12	NP_789792.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	NLRP14	ENST00000299481.5	TSL:5 MANE Select	c.3028C>T	p.Leu1010Phe	missense	Exon 11 of 12	ENSP00000299481.5

Frequencies

GnomAD3 genomes

AF:

0.152

AC:

23045

AN:

152006

Hom.:

2148

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0810

Gnomad AMI

AF:

0.240

Gnomad AMR

AF:

0.154

Gnomad ASJ

AF:

0.200

Gnomad EAS

AF:

0.0144

Gnomad SAS

AF:

0.0852

Gnomad FIN

AF:

0.0972

Gnomad MID

AF:

0.186

Gnomad NFE

AF:

0.213

Gnomad OTH

AF:

0.184

GnomAD2 exomes

AF:

0.148

AC:

37184

AN:

251174

AF XY:

0.151

show subpopulations

Gnomad AFR exome

AF:

0.0772

Gnomad AMR exome

AF:

0.109

Gnomad ASJ exome

AF:

0.192

Gnomad EAS exome

AF:

0.0150

Gnomad FIN exome

AF:

0.103

Gnomad NFE exome

AF:

0.210

Gnomad OTH exome

AF:

0.178

GnomAD4 exome

AF:

0.194

AC:

282213

AN:

1456606

Hom.:

29657

Cov.:

AF XY:

0.192

AC XY:

139294

AN XY:

725018

show subpopulations

African (AFR)

AF:

0.0773

AC:

2584

AN:

33408

American (AMR)

AF:

0.116

AC:

5190

AN:

44704

Ashkenazi Jewish (ASJ)

AF:

0.194

AC:

5067

AN:

26094

East Asian (EAS)

AF:

0.0188

AC:

745

AN:

39646

South Asian (SAS)

AF:

0.0976

AC:

8412

AN:

86170

European-Finnish (FIN)

AF:

0.108

AC:

5739

AN:

53302

Middle Eastern (MID)

AF:

0.172

AC:

987

AN:

5754

European-Non Finnish (NFE)

AF:

0.219

AC:

242516

AN:

1107332

Other (OTH)

AF:

0.182

AC:

10973

AN:

60196

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.461

Heterozygous variant carriers

10381

20763

31144

41526

51907

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Exome Hom

Variant carriers

8108

16216

24324

32432

40540

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.152

AC:

23049

AN:

152124

Hom.:

2148

Cov.:

AF XY:

0.145

AC XY:

10795

AN XY:

74376

show subpopulations

African (AFR)

AF:

0.0810

AC:

3360

AN:

41498

American (AMR)

AF:

0.153

AC:

2346

AN:

15290

Ashkenazi Jewish (ASJ)

AF:

0.200

AC:

693

AN:

3464

East Asian (EAS)

AF:

0.0147

AC:

AN:

5182

South Asian (SAS)

AF:

0.0856

AC:

413

AN:

4822

European-Finnish (FIN)

AF:

0.0972

AC:

1029

AN:

10586

Middle Eastern (MID)

AF:

0.186

AC:

AN:

290

European-Non Finnish (NFE)

AF:

0.213

AC:

14475

AN:

67968

Other (OTH)

AF:

0.182

AC:

384

AN:

2112

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.502

Heterozygous variant carriers

1004

2008

3013

4017

5021

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Genome Hom

Variant carriers

258

516

774

1032

1290

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.195

Hom.:

13758

Bravo

AF:

0.154

TwinsUK

AF:

0.218

AC:

809

ALSPAC

AF:

0.217

AC:

836

ESP6500AA

AF:

0.0836

AC:

368

ESP6500EA

AF:

0.215

AC:

1848

ExAC

AF:

0.149

AC:

18144

Asia WGS

AF:

0.0540

AC:

189

AN:

3478

EpiCase

AF:

0.221

EpiControl

AF:

0.226

ClinVar

Significance: Benign

Submissions summary: Benign:3

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not provided

Benign:2

Breakthrough Genomics, Breakthrough Genomics

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:not provided

Jun 10, 2021

GeneDx

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

NLRP14-related disorder

Benign:1

Oct 21, 2019

PreventionGenetics, part of Exact Sciences

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.16

BayesDel_addAF

Benign

-0.54

BayesDel_noAF

Benign

-0.40

CADD

Benign

(source)

DANN

Uncertain

0.99

DEOGEN2

Benign

0.11

Eigen

Benign

0.041

Eigen_PC

Benign

-0.057

FATHMM_MKL

Benign

0.56

LIST_S2

Benign

0.60

MetaRNN

Benign

0.0011

MetaSVM

Benign

-1.1

MutationAssessor

Pathogenic

3.0

PhyloP100

2.0

PrimateAI

Benign

0.39

PROVEAN

Uncertain

-3.0

REVEL

Benign

0.16

Sift

Benign

0.058

Sift4G

Pathogenic

0.0

Polyphen

0.71

Vest4

0.064

MPC

0.046

ClinPred

0.041

GERP RS

4.1

Varity_R

0.18

gMVP

0.20

Mutation Taster

=84/16

polymorphism (auto)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Variant Effect in Transcripts

RefSeq Transcripts

Ensembl Transcripts

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over